Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoniazid for TB prevention in SLE
NCT06618573Phase 3Recruiting
- Sponsor
- Universitas Padjadjaran
- Start
- Aug 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of isoniazid in Tuberculosis (TB), sponsored by Universitas Padjadjaran. Started Aug 2022; status: recruiting.
02
Drugs
isoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT06618573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06618573.